Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Silicon Motion
SIMO
$8.6B
| $1.43M | ﹤0.01% |
22,295
+554
| +3% | +$36.4K |
|
3427
Energous
WATT
$77.6M
| $1.43M | ﹤0.01% |
828
+110
| +15% | +$200K |
|
3428
Mammoth Energy Services
TUSK
$128M
| $1.42M | ﹤0.01% |
310,369
+3,391
| +1% | +$14K |
|
|
HDSN
3429
Hudson Technologies
HDSN
$254M
| $1.42M | ﹤0.01% |
418,690
+127,523
| +44% | +$307K |
|
|
UBX
3430
DELISTED
Unity Biotechnology
UBX
| $1.42M | ﹤0.01% |
30,625
-24,887
| -45% | -$1.2M |
|
3431
Barclays
BCS
$92.7B
| $1.42M | ﹤0.01% |
146,640
+5,836
| +4% | +$59.6K |
|
3432
Hawthorn Bancshares
HWBK
$269M
| $1.41M | ﹤0.01% |
66,722
-40,050
| -38% | -$804K |
|
|
DMK
3433
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $1.41M | ﹤0.01% |
18,373
+2,988
| +19% | +$182K |
|
3434
DHI Group
DHX
$182M
| $1.41M | ﹤0.01% |
416,798
-330,219
| -44% | -$1.05M |
|
3435
First Western Financial
MYFW
$304M
| $1.41M | ﹤0.01% |
54,380
-23,144
| -30% | -$618K |
|
3436
STRATTEC Security
STRT
$367M
| $1.4M | ﹤0.01% |
31,460
+587
| +2% | +$28.1K |
|
3437
Westwood Holdings Group
WHG
$182M
| $1.4M | ﹤0.01% |
64,236
-42,468
| -40% | -$807K |
|
|
MDVL
3438
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $1.39M | ﹤0.01% |
2,266
+2,002
| +758% | +$1.31M |
|
|
SBBP
3439
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.39M | ﹤0.01% |
466,879
-256,190
| -35% | -$676K |
|
|
FTH
3440
Faeth Therapeutics
FTH
$702M
| $1.38M | ﹤0.01% |
7,090
+1,220
| +21% | +$301K |
|
3441
Weyco Group
WEYS
$372M
| $1.38M | ﹤0.01% |
61,754
-35,800
| -37% | -$767K |
|
|
SFE
3442
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.38M | ﹤0.01% |
177,543
-124,843
| -41% | -$851K |
|
|
TREC
3443
DELISTED
Trecora Resources
TREC
| $1.38M | ﹤0.01% |
165,393
-161,427
| -49% | -$1.3M |
|
3444
Vaalco Energy
EGY
$570M
| $1.37M | ﹤0.01% |
421,598
+24,274
| +6% | +$66.8K |
|
3445
HireQuest
HQI
$180M
| $1.37M | ﹤0.01% |
73,963
+46,270
| +167% | +$890K |
|
3446
Taboola.com
TBLA
$1.37B
| $1.37M | ﹤0.01% |
+132,900
| New | +$1.38M |
|
|
CHMI
3447
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $1.36M | ﹤0.01% |
138,045
-111,855
| -45% | -$1.11M |
|
|
OMP
3448
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $1.36M | ﹤0.01% |
58,067
+47,526
| +451% | +$1.18M |
|
3449
XWELL
XWEL
$8.28M
| $1.36M | ﹤0.01% |
44,115
+7,018
| +19% | +$200K |
|
3450
inTEST
INTT
$155M
| $1.36M | ﹤0.01% |
80,880
+26,348
| +48% | +$356K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.